Ipsen is a global specialty-driven pharmaceutical company. Ipsen’s ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Its development strategy is supported by four franchises: neurology / Dysport®, endocrinology / Somatuline®, uro-oncology / Decapeptyl® and hemophilia. Moreover, the Group has an active policy of partnerships. R&D...
Networks
The Irish Haemophilia Society was founded in 1968 by members of the medical profession, people with haemophilia, their families and friends who felt the need to provide support and advice for members and to improve the quality of life for people with haemophilia.
Progressive Multifocal Leukoencephalopathy is caused by the John Cunningham virus, or JC virus for short.
There mission is to hope, advocacy, and action by vigorously supporting physicians, researchers, and the ever expanding global patient community – directing its efforts toward early diagnosis, meaningful treatments, equal access to care, and ultimately, cures for Primary Immunodeficiency.